Skip to content
Search

Latest Stories

Lords back amendment to exempt pharmacies from national insurance hike

Members of the House of Lords approved four changes to the National Insurance Contributions (Secondary Class 1 Contributions) Bill at the report stage

National Insurance Bill debated in the the House of Lords

National Insurance Bill debated in the the House of Lords

Pharmacies are expected to be exempted from national insurance contributions following an amendment to the National Insurance Contributions (Secondary Class 1 Contributions) Bill, which was approved by the House of Lords on Tuesday, 25 February 2025.

In the 2024 Autumn Budget, Chancellor Rachel Reeves announced an increase in the employer secondary Class 1 National Insurance contributions rate, rising from 13.8% to 15% starting in April 2025.


Health and care providers, including community pharmacists, have been calling on the government to reconsider their decision and grant them an exemption from the increase.

Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA) welcomed the strong backing for this amendment in the Lords, stating: “It is absolutely right that pharmacies should be exempted from the increase to National Insurance contributions.”

He pointed out that pharmacy businesses earn as much as 90-95% of their income by delivering NHS care and services, but the amount that the government pays for these services has not increased since 2014.

“As increased operating costs cannot be passed on to the NHS or to patients, pharmacy businesses have been forced to simply absorb them.

“We urge Peers to pass this amendment and hope that MPs will also follow suit.”

Nick Kaye, Chair of the National Pharmacy Association (NPA), emphasised that this amendment would help pharmacies manage a looming bill of hundreds of millions of pounds.

"This comes in the context of 40 per cent cuts to pharmacy budgets, forcing record numbers to close,” he said.

Kaye reiterated that if the government fails to provide additional support in the new contract, they would be forced to recommend pharmacies to cut back services, including their opening hours, to protect their businesses.

The NPA estimated that rises in National Insurance and the National Living Wage would collectively cost pharmacies across the UK £310 million.

Baroness Barker, who introduced the amendment, warned that sudden changes to national insurance, along with the increases in the minimum wage, could threaten “the existence of large numbers of providers and have a profound impact on budgets.”

Lords voted to agree four changes to the Bill aimed at maintaining current national insurance contribution rates or granting exemptions from the planned increase. These changes apply to:

  • Health and care providers, including GPs, dentists and pharmacists
  • Charities with annual revenue less than £1 million
  • Transport providers for children with special educational needs and disabilities
  • Low earning or low employee businesses and organisations.

Additionally, members agreed to increase employment allowance in the early years sector to £20,000 and require

However, two proposed amendments—one on new contribution rates for part-time workers and another on maintaining current rates for sectors such as universities, councils, and housing associations—were put to a vote but rejected.

The Third Reading, which ensures the new law is effective, workable and without loopholes, is scheduled for 4 March.

More For You

NHS England chief Amanda Pritchard steps down

Amanda Pritchard

REUTERS

NHS England chief Amanda Pritchard steps down, Sir James Mackey named successor

Amanda Pritchard has announced her decision to stand down as chief executive of NHS England at the end of this financial year.

Pritchard, who has led NHS England since August 2021, made history as the first woman to hold the post, playing a pivotal role in steering the NHS through the Covid-19 pandemic. Previously, she served as chief operating officer from 2019.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less
Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
CPCF negotiations: CPE working to secure the best outcomes for the sector
Pharmacy sector demands urgent resolution of CPCF negotiations (gettyimages)

CPCF Negotiations: CPE unable to share details until official announcement

Acknowledging the sector's urgent need to resolve CPCF negotiations, CPE reiterates its commitment to securing the best possible outcome

Community Pharmacy England (CPE) has provided an update on the ongoing 2024/25 and 2025/26 Community Pharmacy Contractual Framework (CPCF) negotiations with the Department of Health and Social Care (DHSC) and NHS England.

“The Negotiating Team are continuing in-depth negotiations with DHSC and NHS England,” the Committee said, adding that they are focused on securing the “best outcomes” for pharmacy owners.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less